What does CUSIP 45773HAB8 represent in this 13F holders report?

CUSIP 45773HAB8 is the security identifier for 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 used to aggregate holder disclosures.

How many institutions held 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 in Q1 2020?

15 institutional investors reported 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 for Q1 2020. Use the holders table for investor-level position and value details.

INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0

CUSIP: 45773HAB8

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Debt / NOTE 6.500% 3/0
Market price (% of par): 148.67%
Total 13F principal: $75,623,000
Principal change: +$75,623,000
Total reported market value: $111,636,000
Number of holders: 15
Value change: +$111,636,000
Number of buys: 15

Quarterly Holders Quick Answers

What is CUSIP 45773HAB8?
CUSIP 45773HAB8 identifies 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020

Recent filing periods for CUSIP 45773HAB8:

Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022

Institutional Holders of INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 as of Q1 2020

As of 31 Mar 2020, INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 was held by 15 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $75,623,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Context Capital Management, LLC, D. E. Shaw & Co., Inc., CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, SOROS FUND MANAGEMENT LLC, CVI Holdings, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 15 institutional bondholders reporting positions for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.